Therapeutic approach to the distal airways in asthma;Abordaje terapéutico de la vía aérea pequeña en el asma

Archivos de Bronconeumologia

Volumn 47, Issue SUPPL. 2, 2011, Pages 27-31

  De Diego Damiá, Alfredo ^a   Vega Chicote, José María ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Asthma; Hydrofluoroalkane; Lung deposition; New antiinflammatory agents; Small airways

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG;

AIRWAY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHIOLE; BRONCHODILATATION; CHRONIC INFLAMMATION; DISTAL AIRWAY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; HUMAN; LUNG RESISTANCE; LUNG VOLUME; OROPHARYNX; SMALL AIRWAY DISEASE; TRACHEOBRONCHIAL TREE;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; AIRWAY OBSTRUCTION; AIRWAY REMODELING; AIRWAY RESISTANCE; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHIOLES; BRONCHODILATOR AGENTS; EQUIPMENT DESIGN; HUMANS; INFLAMMATION; LEUKOTRIENE ANTAGONISTS; NEBULIZERS AND VAPORIZERS; PULMONARY ALVEOLI; TISSUE DISTRIBUTION;

EID: 79957851316     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(11)70008-4     Document Type: Article

References (38)

1. Hamid Q., Song Y., Kotsimbos T.C., Minshall E., Bai T.R., Hegele R.G., et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997, 100:44-51.
2. Bacsi A., Choudhury B.K., Dharajiya N., Sur S., Boldogh I. Subpollen particles: carriers of allergenic proteins and oxidases. J Allergy Clin Immunol 2006, 118:844-850.
3. Adcock I.M., Gilbey T., Gelder C.M., Chung K.F., Barnes P.J. Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med 1996, 154:771-782.
4. Bousquet J., Clark T.J., Hurd S., Khaltaev N., Lenfant C., O'Byrne P., et al. GINA guidelines on asthma and beyond. Allergy 2007, 62:102-112.
5. Humbert M., Holgate S., Boulet L.P., Bousquet J. Asthma control or severity: that is the question. Allergy 2007, 62:95-101.
6. Cazzoletti L., Marcon A., Janson C., Corsico A., Jarvis D., Pin I., et al. Asthma control in Europe: a realworld evaluation based on an international population-based study. J Allergy Clin Immunol 2007, 120:1360-1367.
7. Leach C.L., Davidson P.J., Boudreau R.J. Improved airway targeting with the CFCfree HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998, 12:1346-1353.
8. Leach C., Colice G.L., Luskin A. Particle size of inhaled corticosteroids: Does it matter?. J Allergy Clin Immunol 2009, 124:S88-S93.
9. Gabrio B.J., Stein S.W., Velasquez D.J. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int J Pharm 1999, 186:3-12.
10. Leach C. Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol 1999, 104(Suppl):250-252.
11. Van Schayck C.P., Donnell D. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults. Int J Clin Pract 2004, 58:678-688.
12. Papi A., Paggiaro P.L., Nicolini G., Vignola A.M., Fabbri L.M. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007, 29:682-689.
13. Ohbayashi H. One-year evaluation of the preventative effect of hydrofluoroalkane- beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways. Respiration 2007, 74:146-153.
14. Laurent F., Latrabe V., Raherison C., Martham R., Tunon de Lara J.M. Fuctional significance of air trapping detected in moderate asthma. Eur Radiol 2000, 10:1404-1410.
15. Ito R., Yokoyama A., Hamada H., Yasukara Y., Kohno N., Higaki J. Effect of inhaled bronchodilators on air trapping in patients with stable asthma. J Asth 2006, 43:125-129.
16. Beigelman-Aubry C., Capderou A., Grenier P.A., Straus C., Becquemin M.H., Similowski T., et al. CT assessment of bronchial cross-sectional area and lung attenuation at controlled lung volume. Radiology 2002, 223:181-187.
17. Cooper P., Panettieri R.A. Steroids completely reverse albuterol induced beta2 adrenergic receptor tolerance in human small airways. J Allergy Clin Immunol 2008, 122:734-740.
18. Langley S.J., Houghton C.M., Singh S.D. Bronchoprotective and bronchodilators effects of an HFA pMDI vs. a CFC pMDI and a DPI contanining formoterol in asthma patients. Respiration 2005, 72:35-37.
19. Hauber H.P., Gotfried M., Newman K., Danda R., Servi R.J., Christodoulopoulos P., et al. Effects of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol 2003, 112:58-63.
20. Bergeron C., Hauber H.P., Gotfried M., Newman K., Dhanda R., Servi R.J., et al. Evidence of remodelling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. J Allergy Clin Immunol 2005, 116:983-989.
21. Goldin J.G., Tashkin D.P., Kleerup E.C., Greaser L.E., Haywood U.M., Sayre J.W., et al. Comparative effects of hydrofluoroalkane and chlorofluorobechlometasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999, 104(Suppl):258-267.
22. Tunon de Lara J.M., Laurent F., Giraud V., Perez T., Aguilaniu B., Mezine H., et al. Air trapping in mild and moderate asthma: effects of inhaled corticosteroids. J Allergy Clin Immunol 2007, 119:583-590.
23. De Backer W., Devolder A., Poli G., Acerbi D., Monno R., Herpich C., et al. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv 2010, 23:137-148.
24. Scichilone N., Battaglia S., Sorino C., Paglino G., Martino L., Paternò A., et al. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. Allergy 2010, 65:897-902.
25. Thongngarm T., Silkoff P.E., Kossak H.S., Nelson W.S. HFA-134A bechlometasone or CFC fluticasone: effect on small airways in poorly controlled asthma. J Asthma 2005, 42:257-263.
26. Newman S., Salmon A., Nave R., Drollmann A. High Lung deposition of 99mTc-labeled ciclesonide adminesterd via HFA-MDI to patients with asthma. Resp Med 2006, 100:375-384.
27. Papi A., Paggiaro P., Nicolini G., Vignola A.M., Fabbri LM Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy 2007, 62:1182-1188. ICAT SE study group.
28. Cohen J., Douma W.R., Hacken N.H.T., Vonk J.M., Postma D.S. Ciclesonide improves measures of small airways involvement in asthma. Eur Respir J 2008, 31:1213-1220.
29. Hoshino M. Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma. Allergol Int 2010, 59:59-66.
30. Cohen J, Postma DS, Douma WR, Vonk JM, De Boer AH, Ten Hacken NH. Particle size matters: diagnostic and treatment of small airways involvement in asthma. Eur Respir J. 20010. En prensa.
31. Lehtimaki L., Kankaanranta H., Saarelainee, Turjanmaa V., Moilanen E. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 2001, 18:635-639.
32. Verbanck S., Schuermans D., Vincken W. Inflammation and airway function in the lung periphery of patients with stable asthma. J Allergy Clin Immunol 2010, 125:611-616.
33. Verbanck S., Schuermans D., Pavia M., Vincken W. The functional benefit of anti-inflammatory aerosols in the lung periphery. J Allergy Clin Immunol 2006, 118:340-346.
34. Leung S.Y., Eynott P., Puntea N., Chung K.F. Effects of ciclesonide and fluticasone propionate on allergen-induced airway inflammation and remodeling features. J Allergy Clin Immunol 2005, 115:989-996.
35. Lemanske R.F., Mauger D.T., Sorkness C.A., Jackson D.J., Boehmer S.J., Martinez F.D., et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010, 362:975-985.
36. Spahn J.D., Covar R.A., Jain N., Gleason M., Shimamoto R., Szefler S.J., Gelfand E.W. Effect of montelukast on peripheral airflow obstruction in children with asthma. Ann Allergy Asthma Immunol 2006, 96:541-549.
37. Zeidler M.R., Kleerup E.C., Goldin J.G., Kim H.J., Truong D.A., Simmons M.D., et al. Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J 2006, 27:307-315.
38. Mechiche H., Naline E., Candenas L., Pinto F.M., Birembault P., Advenier C., Devillier P. Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolites. Clin Exp Allergy 2003, 33:887-894.